Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study
- PMID: 36696286
- DOI: 10.1111/jvh.13807
Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study
Abstract
Expanding capacity to screen and treat those infected with the hepatitis C virus (HCV) is an essential element of the global elimination strategy. We evaluated the hub-and-spoke Project ECHO training versus telementoring models to educate, train and support HCV care by primary care providers in 13 targeted counties in northern California. A novel provider engagement strategy was used. Provider engagement and retention, time to readiness to treat HCV, and knowledge and confidence were the outcomes of interest. 94 participants from 60 unique clinics in the target counties participated in the ECHO-PLUS programme; 39.4% were physicians, 48.9% were advanced practice providers, and 11.7% were nurses. The median (range) participation time was 5 (1-49) hours. Confidence scores (minimum score = 13 and maximum score = 65) increased by a mean of 14.0 (SD:8.2) and 11.4 (SD:12.0) points for the hub-and-spoke and telementoring programmes, respectively (p = .53), with the largest changes in confidence seen in treating patients per guidelines, managing side effects and in serving as a consultant for HCV in their clinic. Among 24 participants with data on time to treatment, median time from beginner to experienced was 8 h (IQR:6-12) for hub-and-spoke and 2 h (IQR:1-2.4) for the telementoring programme (p = .01). A 'boots on the ground' approach to recruiting HCV champions was effective within rural communities. Both tele-ECHO hub-and-spoke and telementoring approaches to training primary care providers yielded increase in knowledge and confidence in HCV care and amplified the number of patients who were screened and treated. Telementoring accelerated the timeline of novice providers being 'ready to treat'.
Keywords: elimination; hub and spoke; screening; telementoring; treatment.
© 2023 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Rosenberg ES, Rosenthal EM, Hall EW, et al. Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1:e186371.
-
- Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364:2199-2207.
-
- Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment-extension for community healthcare outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. 2010;52:1124-1133.
-
- Piao C, Terrault NA, Sarkar S. Telemedicine: an evolving field in Hepatology. Hepatol Commun. 2019;3:716-721.
-
- Rossaro L, Torruellas C, Dhaliwal S, et al. Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in northern California. Dig Dis Sci. 2013;58:3620-3625.

